AzTrials
AzTrials

Falls PreventionNCT05615077

Multidisciplinary Combined Exercise and Education Intervention for Falls in Older Adults

A study testing Combined exercise-education intervention in people with Falls Prevention, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to demonstrate the effect of combined exercise-education intervention in old adults with fall risk. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-education intervention with conventional medical care. Read more about this study

Who is it for?
Ages 65 to 95 years
Conditions the study is for
Falls Prevention
What is being tested?
Combined exercise-education intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
484 participants
Where
1 siteSouth Korea
Study dates
24 Nov 2022to 31 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • patients older than 65 years and under 90 years
  • if at least one <3 key question> is met or <stay independent score> ≥ 4 points
  • patients who can walk more than 10m without an assistive device (ambulatory without an assistive device)
  • patients who are willing to participate in exercise intervention for 12 months
  • patients who can receive information about this study, submit written consent before participating in the study, and can comply with the requirements of the clinical trial

Who cannot join

  • medically unstable conditions (e.g., cirrhosis with complications, end-stage renal failure requiring regular dialysis, hemorrhagic disease, uncontrolled hypertension, those who have been treated for a malignant tumor within 5 years)
  • in case of ongoing neurological deficit except for stroke survivors (e.g., dementia, Alzheimer's disease, Parkinson's disease, etc.)
  • decreased cardiopulmonary function such as heart failure, chronic obstructive pulmonary disease
  • musculoskeletal problems that affect physical function and athletic ability (e.g., those who have undergone hip joint surgery, artificial joint surgery, spine surgery within the last 1 year)
  • patients who have experienced alcohol abuse within the last 1 year (if 3 or more are meet in Cut off, Annoyed, Guilty, Eye opener [CAGE] evaluation)
  • in case the purpose of this clinical trial cannot be understood or the matters necessary for the study cannot be carried out
  • when it is judged by other researchers that the subject's condition makes it difficult to participate in this study

Trial locations and contacts

1 site in 1 country.

Keewon Kim, MD, PhD contact

+82-10-6238-9649

keewonkimm.d@gmail.com

Seongdae Kim, PhD contact

+82-10-3059-3217

kimsd@snu.ac.kr

South Korea1 site, 1 recruiting
  • Seoul National University Hospital

    Seoul, 03080

    Keewon Kim, MD, PhD

    Keewon Kim, MD, PhD

    Recruiting

Other trials in South Korea

About this study

Official title: Effectiveness of Comprehensive Intervention for the Prevention of Fall in Older Adults; a Randomized Controlled Trial

This study aims to demonstrate the effect of combined exercise-education intervention in old adults with fall risk. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-education intervention with conventional medical care. Falls efficacy scale-international, fall history, Balance function, handgrip strength, gait speed, knee extensor muscle power, physical performance, muscle mass using DEXA and BIA, quality of life, depression, cognitive function, activities of daily living, nutritional assessment will be evaluated on baseline, 1-month, 3-months, 6-months, and 12-months after intervention.

Read the detailed description

A fall is defined as an event which results in a person coming to rest inadvertently on the ground or floor or other lower level. And also, falls are the second leading cause of unintentional injury deaths worldwide. In particular, adults older than 65 years of age suffer the greatest number of fatal falls. It has been reported exercise in fall risk patients not only improved physical performance but also reduced the fall risk. Also, it is recently demonstrated that combined exercise-education (e.g., exercise training, medication review, nutrition counseling, home hazards modification) intervention reduced fall risk in elderly patients. However, there is still not established standard protocol for the combined exercise-education intervention. Therefore, the aim of this trial is to compare the effects of combined exercise-education intervention in fall risk patients with multicenter, multidisciplinary, randomized controlled trial.

Being tested
Combined exercise-education intervention
Keywords
Falls, exercise, education, elderly
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined exercise-education interventionOther

    Combined exercise and education intervention by fall risk state for 12 months during intervention period.

    Exercise intervention includes balance exercise and strength exercise according to protocol.

    Education intervention includes medication review, nutrition intervention, and home hazard modification.

    The key to medication review is paying special attention to medications known to increase the risk of falls. Reduction of these medications is recommended, and redundant psychotropic medications are withdrawn. Nutrition intervention includes investigating dietary habits and calculate insufficient protein intake to provide customized diet and high protein drink. If vitamin D necessary, supplements are prescribed. Home hazard modification includes providing instructions to reduce and modify the home hazards that increase the risk of falls.

Study groups in NCT05615077
Study groupRoleWhat they receive
Combined exercise-education intervention groupExperimentalCombined exercise-education intervention by fall risk state for 12 months during intervention period.
Receives: Other: Combined exercise-education intervention
Control groupNo interventionNo intervention for 12 months during intervention period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Korean Version of Falls Efficacy Scale-International (KFES-I)

    Change from baseline falls efficacy to 1, 3, 6, 12 months after assessment, measured by Korean Version of Falls Efficacy Scale-International (KFES-I) [range from 16 to 64]. A higher value represents a high concern for falling.

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

Secondary outcomes (13)
  1. Falls history & injury

    Evaluation of number of falls and type of falls in previous 12 months

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  2. Physical performance

    Short Physical Performance Battery [range from 0 to 12 score]

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  3. Gait speed test

    measured by 10 meter gait speed

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  4. Balance function

    Evaluation of physical balance function using Mini-Balance Evaluation System Test (Mini-BESTest) [range from 0 to 28]. Low value means poor ability of balance function.

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  5. Handgrip strength

    measured in kilograms (kg) using hand-held dynamometer

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  6. Knee extensor muscle test

    measured using a belt-stabilized hand-held dynamometer

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  7. Physical activity volume

    Evaluation of physical activity volume using Korean version of Physical Activity Scale for the Elderly (K-PASE) [range from 0 to 360 score]. Low value means poor physical activity

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  8. Cognitive function

    Evaluation of cognitive function using Korean-Montreal Cognitive Assessment (K-MoCA) [range from 0 to 30 score]. Low value means poor cognitive function

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  9. Health related quality of life

    Evaluation of quality of life using EuroQol-5 dimension (EQ-5D) [range from 5 to 25 score]. Higher value means worse quality of life

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  10. Depression status

    Evaluation of depression status using Patient Health Questionnaire-9 (PHQ-9) [range from 0 to 27 score]. Higher score indicates a higher severity of depressive symptoms

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  11. Nutritional Assessment

    Evaluation of nutritional state using Mini-Nutritional Assessment short form (MNA-SF) [range from 0 to 14 score]. Low value means poor nutrition status

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  12. Appendicular skeletal muscle mass

    measured using Bioelectrical Impedance Analysis (BIA)

    Measured: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)

  13. Bone density

    measured using Dual-energy X-ray absorptiometry (DEXA)

    Measured: Baseline (visit 1), 12 months after intervention (visit 5)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2022
  2. Study start24 Nov 2022
  3. Primary completion31 May 2025 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
484 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05615077
Sponsor's protocol ID
H-2208-176-1354
Status last verified
Jan 2023
First submitted
3 Nov 2022
Last updated
27 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Palvanen M, Kannus P, Piirtola M, Niemi S, Parkkari J, Jarvinen M. Effectiveness of the Chaos Falls Clinic in preventing falls and injuries of home-dwelling older adults: a randomised controlled trial. Injury. 2014 Jan;45(1):265-71. doi: 10.1016/j.injury.2013.03.010. Epub 2013 Apr 8.

    PubMed 23579066

Questions about this trial

What is this clinical trial studying?

A study testing Combined exercise-education intervention in people with Falls Prevention, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Keewon Kim, MD, PhD (+82-10-6238-9649, keewonkimm.d@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Korean Version of Falls Efficacy Scale-International (KFES-I) (time frame: Baseline (visit 1), 1 month after intervention (visit 2), 3 months after intervention (visit 3), 6 months after intervention (visit 4), 12 months after intervention (visit 5)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05615077, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in